Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates
- 11 September 2015
- journal article
- review article
- Published by Wiley in Medicinal Research Reviews
- Vol. 36 (1), 32-91
- https://doi.org/10.1002/med.21377
Abstract
Natural products have made significant contribution to cancer chemotherapy over the past decades and remain an indispensable source of molecular and mechanistic diversity for anticancer drug discovery. More often than not, natural products may serve as leads for further drug development rather than as effective anticancer drugs by themselves. Generally, optimization of natural leads into anticancer drugs or drug candidates should not only address drug efficacy, but also improve absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles and chemical accessibility associated with the natural leads. Optimization strategies involve direct chemical manipulation of functional groups, structure–activity relationship directed optimization and pharmacophore‐oriented molecular design based on the natural templates. Both fundamental medicinal chemistry principles (e.g., bioisosterism) and state‐of‐the‐art computer‐aided drug design techniques (e.g., structure‐based design) can be applied to facilitate optimization efforts. In this review, the strategies to optimize natural leads to anticancer drugs or drug candidates are illustrated with examples and described according to their purposes. Furthermore, successful case studies on lead optimization of bioactive compounds performed in the Natural Products Research Laboratories at UNC are highlighted.Keywords
Funding Information
- National Natural Science Foundation of China (81172985, 81261120391)
- NIH (CA177584)
This publication has 164 references indexed in Scilit:
- Charting, Navigating, and Populating Natural Product Chemical Space for Drug DiscoveryJournal of Medicinal Chemistry, 2012
- Classification of scaffold-hopping approachesDrug Discovery Today, 2012
- Natural products: An evolving role in future drug discoveryEuropean Journal of Medicinal Chemistry, 2011
- Chemoinformatic Analysis of Combinatorial Libraries, Drugs, Natural Products, and Molecular Libraries Small Molecule RepositoryJournal of Chemical Information and Modeling, 2009
- From nature to the laboratory and into the clinicBioorganic & Medicinal Chemistry, 2009
- Irofulven induces replication-dependent CHK2 activation related to p53 statusBiochemical Pharmacology, 2007
- Antitumor Agents. 250. Design and Synthesis of New Curcumin Analogues as Potential Anti-Prostate Cancer AgentsJournal of Medicinal Chemistry, 2006
- Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial ChemistryJournal of Chemical Information and Computer Sciences, 2002
- Natural Products in Drug Discovery and DevelopmentJournal of Natural Products, 1997
- Phase II study of elliptinium acetate salvage treatment of advanced breast cancerEuropean Journal of Cancer, 1993